Table 1.

Clinicopathological information of the ascites-derived primary EOC cells

Sample ID	Age	Histological Type	Stage	Upfront Diagnosis/Recurrent	Response to Treatment
EOC6	75	High grade serous EOC	IV	Upfront diagnosis	Patient declined treatment, went to palliative care
EOC8	54	High grade serous EOC	IV	Rercurrent, previously treated with Carboplatin/Taxol and Gemcitabine	No response to first line chemotherapy, progressed on treatment
EOC9	46	High grade serous EOC	IIIC	Upfront diagnosis	Responsive to treatment, 15 months from treatment and no recurrence
EOC11	53	High grade serous EOC	IIIC	Recurrent, previously treated with Carboplatin/Taxol	Responsive to treatment, recurred at 12 months
EOC15	73	High grade serous EOC	IIIC	Recurrent, previously treated with Carboplatin/Taxol	Responsive to treatment, recurred at 7 months
EOC21	74	High grade serous EOC	IIIC	Recurrent, previously treated with Carboplatin	Responsive to treatment, recurred at 6 months